Literature DB >> 15521447

Use of low molecular weight heparin in cats: 57 cases (1999-2003).

Caren E Smith1, Elizabeth A Rozanski, Lisa M Freeman, Donald J Brown, Jennifer S Goodman, John E Rush.   

Abstract

OBJECTIVE: To determine duration of administration, complications, and frequency of aortic thromboembolism associated with administration of low molecular weight heparin (dalteparin) in cats.
DESIGN: Retrospective study. ANIMALS: 57 cats treated with dalteparin PROCEDURE: Data were recorded from the medical records of cats treated with dalteparin, and owners were contacted by telephone for information regarding ease of administration and possible adverse effects.
RESULTS: Dalteparin was easily administered by owners. Median dose was 99 U/kg (45 U/lb) once or twice daily. Bleeding complications were infrequent. Of 43 cats with cardiomyopathy that received owner-administered dalteparin for a median follow-up time of 172 days, 8 cats developed documented or possible arterial thromboembolism. CONCLUSIONS AND CLINICAL RELEVANCE: Dalteparin was easily administered by owners and was well tolerated by cats. Whether dalteparin administration can reduce the frequency or severity of arterial thromboembolism is not yet known.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15521447     DOI: 10.2460/javma.2004.225.1237

Source DB:  PubMed          Journal:  J Am Vet Med Assoc        ISSN: 0003-1488            Impact factor:   1.936


  4 in total

1.  The effect of a low molecular weight heparin on coagulation parameters in healthy cats.

Authors:  Cheryl L Vargo; Susan M Taylor; Anthony Carr; Marion L Jackson
Journal:  Can J Vet Res       Date:  2009-04       Impact factor: 1.310

2.  Retrospective Evaluation of Intravenous Enoxaparin Administration in Feline Arterial Thromboembolism.

Authors:  Athanasia Mitropoulou; Esther Hassdenteufel; Joanna Lin; Natali Bauer; Gabriel Wurtinger; Claudia Vollmar; Estelle Henrich; Nicolai Hildebrandt; Matthias Schneider
Journal:  Animals (Basel)       Date:  2022-08-04       Impact factor: 3.231

3.  2022 Update of the Consensus on the Rational Use of Antithrombotics and Thrombolytics in Veterinary Critical Care (CURATIVE) Domain 1- Defining populations at risk.

Authors:  Armelle deLaforcade; Lenore Bacek; Marie-Claude Blais; Corrin Boyd; Benjamin M Brainard; Daniel L Chan; Stefano Cortellini; Robert Goggs; Guillaume L Hoareau; Amy Koenigshof; Ron Li; Alex Lynch; Alan Ralph; Elizabeth Rozanski; Claire R Sharp
Journal:  J Vet Emerg Crit Care (San Antonio)       Date:  2022-05-02

4.  Arterial thromboembolism in 250 cats in general practice: 2004-2012.

Authors:  K Borgeat; J Wright; O Garrod; J R Payne; V L Fuentes
Journal:  J Vet Intern Med       Date:  2013-11-15       Impact factor: 3.333

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.